We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique network-driven drug discovery ("NDD") methodology which allows us to discover novel and better drugs faster.
ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Join our audience of astute high net worth investors, fund managers, private client brokers and analysts
Look beyond the numbers and meet the people creating the value for shareholders
Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
Watch the event afterwards on our YouTube channel
One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.